{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,30]],"date-time":"2026-09-30T20:50:31Z","timestamp":1790801431545,"version":"4.1.0"},"reference-count":54,"publisher":"Springer Science and Business Media LLC","issue":"8","license":[{"start":{"date-parts":[[2025,8,19]],"date-time":"2025-08-19T00:00:00Z","timestamp":1755561600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2025,8,19]],"date-time":"2025-08-19T00:00:00Z","timestamp":1755561600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Nat Metab"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>\n                    Dual agonists targeting glucagon-like peptide-1 receptor (GLP1R) and glucose-dependent insulinotropic polypeptide receptor (GIPR) are breakthrough treatments for patients with type 2 diabetes and obesity. Compared to GLP1R agonists, dual agonists show superior efficacy for glucose lowering and weight reduction. However, delineation of dual agonist cell targets remains challenging. Here, we develop and test daLUXendin and daLUXendin+, non-lipidated and lipidated fluorescent GLP1R\/GIPR dual agonist probes, and use them to visualize cellular targets. daLUXendins are potent GLP1R\/GIPR dual agonists that advantageously show less functional selectivity for mouse GLP1R over mouse GIPR. daLUXendins label rodent and human pancreatic islet cells, with a signal intensity of \u03b2\u2009cells\u2009&gt;\u2009\u03b1\u2009cells\u2009=\u2009\u03b4\u2009cells. Systemic administration of daLUXendin strongly labels GLP1R\n                    <jats:sup>+<\/jats:sup>\n                    and GIPR\n                    <jats:sup>+<\/jats:sup>\n                    neurons in circumventricular organs characterized by an incomplete blood\u2013brain barrier but does not penetrate the brain beyond labelling seen with single (ant)agonists. At the single-molecule level, daLUXendin targets endogenous GLP1R\u2013GIPR nanodomains, which differ in organization and composition from those targeted by a single agonist. daLUXendins reveal dual agonist targets in the pancreas and brain and exclude a role for brain penetration in determining the superior efficacy of dual agonists, shedding new light on different modes of action of dual agonists versus single agonists.\n                  <\/jats:p>","DOI":"10.1038\/s42255-025-01342-6","type":"journal-article","created":{"date-parts":[[2025,8,19]],"date-time":"2025-08-19T09:04:05Z","timestamp":1755594245000},"page":"1536-1549","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":18,"title":["Fluorescent GLP1R\/GIPR dual agonist probes reveal cell targets in the pancreas and brain"],"prefix":"10.1038","volume":"7","author":[{"given":"Anne","family":"de Bray","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anna G.","family":"Roberts","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sarah","family":"Armour","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1027-3662","authenticated-orcid":false,"given":"Jason","family":"Tong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9862-8784","authenticated-orcid":false,"given":"Christiane","family":"Huhn","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Blaise","family":"Gatin-Fraudet","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kilian","family":"Ro\u00dfmann","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ali H.","family":"Shilleh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wanqing","family":"Jiang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Natalie S.","family":"Figueredo Burgos","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"James P. P.","family":"Trott","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Katrina","family":"Viloria","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daniela","family":"Nasteska","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9845-0541","authenticated-orcid":false,"given":"Abigail","family":"Pearce","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1781-1590","authenticated-orcid":false,"given":"Satsuki","family":"Miyazaki","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3170-8533","authenticated-orcid":false,"given":"Jeremy W.","family":"Tomlinson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5284-2782","authenticated-orcid":false,"given":"Dylan M.","family":"Owen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0873-4418","authenticated-orcid":false,"given":"Daniel J.","family":"Nieves","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0039-4762","authenticated-orcid":false,"given":"Julia","family":"Ast","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Malgorzata","family":"Cyranka","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alexey","family":"Epanchintsev","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carina","family":"\u00c4mm\u00e4l\u00e4","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9399-6377","authenticated-orcid":false,"given":"Frank","family":"Reimann","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tolga","family":"Soykan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7320-9612","authenticated-orcid":false,"given":"Graham","family":"Ladds","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1279-4763","authenticated-orcid":false,"given":"Alice E.","family":"Adriaenssens","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0665-4948","authenticated-orcid":false,"given":"Stefan","family":"Trapp","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0461-2584","authenticated-orcid":false,"given":"Ben","family":"Jones","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3084-6595","authenticated-orcid":false,"given":"Johannes","family":"Broichhagen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8641-8568","authenticated-orcid":false,"given":"David J.","family":"Hodson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,8,19]]},"reference":[{"key":"1342_CR1","doi-asserted-by":"publisher","first-page":"2075","DOI":"10.1038\/s42255-023-00931-7","volume":"5","author":"A Liskiewicz","year":"2023","unstructured":"Liskiewicz, A. et al. Glucose-dependent insulinotropic polypeptide regulates body weight and food intake via GABAergic neurons in mice. Nat. Metab. 5, 2075\u20132085 (2023).","journal-title":"Nat. Metab."},{"key":"1342_CR2","doi-asserted-by":"publisher","first-page":"1254","DOI":"10.1038\/nm1196-1254","volume":"2","author":"LA Scrocchi","year":"1996","unstructured":"Scrocchi, L. A. et al. Glucose intolerance but normal satiety in mice with a null mutation in the glucagon-like peptide 1 receptor gene. Nat. Med. 2, 1254\u20131258 (1996).","journal-title":"Nat. Med."},{"key":"1342_CR3","doi-asserted-by":"publisher","first-page":"69","DOI":"10.1038\/379069a0","volume":"379","author":"MD Turton","year":"1996","unstructured":"Turton, M. D. et al. A role for glucagon-like peptide-1 in the central regulation of feeding. Nature 379, 69\u201372 (1996).","journal-title":"Nature"},{"key":"1342_CR4","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1056\/NEJMoa1411892","volume":"373","author":"X Pi-Sunyer","year":"2015","unstructured":"Pi-Sunyer, X. et al. A randomized, controlled trial of 3.0 mg of liraglutide in weight management. N. Engl. J. Med. 373, 11\u201322 (2015).","journal-title":"N. Engl. J. Med."},{"key":"1342_CR5","doi-asserted-by":"publisher","first-page":"989","DOI":"10.1056\/NEJMoa2032183","volume":"384","author":"JPH Wilding","year":"2021","unstructured":"Wilding, J. P. H. et al. Once-weekly semaglutide in adults with overweight or obesity. N. Engl. J. Med. 384, 989 (2021).","journal-title":"N. Engl. J. Med."},{"key":"1342_CR6","doi-asserted-by":"publisher","first-page":"738","DOI":"10.1038\/nm727","volume":"8","author":"K Miyawaki","year":"2002","unstructured":"Miyawaki, K. et al. Inhibition of gastric inhibitory polypeptide signaling prevents obesity. Nat. Med. 8, 738\u2013742 (2002).","journal-title":"Nat. Med."},{"key":"1342_CR7","doi-asserted-by":"publisher","first-page":"301","DOI":"10.1172\/JCI116186","volume":"91","author":"MA Nauck","year":"1993","unstructured":"Nauck, M. A. et al. Preserved incretin activity of glucagon-like peptide 1 [7\u201336 amide] but not of synthetic human gastric inhibitory polypeptide in patients with type-2 diabetes mellitus. J. Clin. Invest. 91, 301\u2013307 (1993).","journal-title":"J. Clin. Invest."},{"key":"1342_CR8","doi-asserted-by":"publisher","first-page":"84","DOI":"10.1038\/nm.3997","volume":"22","author":"JE Campbell","year":"2016","unstructured":"Campbell, J. E. et al. TCF1 links GIPR signaling to the control of beta cell function and survival. Nat. Med. 22, 84\u201390 (2016).","journal-title":"Nat. Med."},{"key":"1342_CR9","doi-asserted-by":"publisher","first-page":"1519","DOI":"10.1016\/j.cmet.2023.07.010","volume":"35","author":"JE Campbell","year":"2023","unstructured":"Campbell, J. E. et al. GIPR\/GLP-1R dual agonist therapies for diabetes and weight loss\u2014chemistry, physiology, and clinical applications. Cell Metab. 35, 1519\u20131529 (2023).","journal-title":"Cell Metab."},{"key":"1342_CR10","doi-asserted-by":"publisher","first-page":"e140532","DOI":"10.1172\/jci.insight.140532","volume":"5","author":"FS Willard","year":"2020","unstructured":"Willard, F. S. et al. Tirzepatide is an imbalanced and biased dual GIP and GLP-1 receptor agonist. JCI Insight 5, e140532 (2020).","journal-title":"JCI Insight"},{"key":"1342_CR11","doi-asserted-by":"publisher","first-page":"945","DOI":"10.1038\/s42255-023-00811-0","volume":"5","author":"K El","year":"2023","unstructured":"El, K. et al. The incretin co-agonist tirzepatide requires GIPR for hormone secretion from human islets. Nat. Metab. 5, 945\u2013954 (2023).","journal-title":"Nat. Metab."},{"key":"1342_CR12","doi-asserted-by":"publisher","first-page":"e2116506119","DOI":"10.1073\/pnas.2116506119","volume":"119","author":"B Sun","year":"2022","unstructured":"Sun, B. et al. Structural determinants of dual incretin receptor agonism by tirzepatide. Proc. Natl Acad. Sci. USA 119, e2116506119 (2022).","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"1342_CR13","doi-asserted-by":"publisher","first-page":"103739","DOI":"10.1016\/j.ebiom.2021.103739","volume":"74","author":"J Ast","year":"2021","unstructured":"Ast, J., Broichhagen, J. & Hodson, D. J. Reagents and models for detecting endogenous GLP1R and GIPR. EBioMedicine 74, 103739 (2021).","journal-title":"EBioMedicine"},{"key":"1342_CR14","doi-asserted-by":"publisher","first-page":"987","DOI":"10.1016\/j.cmet.2019.07.013","volume":"30","author":"AE Adriaenssens","year":"2019","unstructured":"Adriaenssens, A. E. et al. Glucose-dependent insulinotropic polypeptide receptor-expressing cells in the hypothalamus regulate food intake. Cell Metab. 30, 987\u2013996.e6 (2019).","journal-title":"Cell Metab."},{"key":"1342_CR15","doi-asserted-by":"publisher","first-page":"1224","DOI":"10.2337\/db13-1440","volume":"63","author":"P Richards","year":"2013","unstructured":"Richards, P. et al. Identification and characterization of GLP-1 receptor-expressing cells using a new transgenic mouse model. Diabetes 63, 1224\u20131233 (2013).","journal-title":"Diabetes"},{"key":"1342_CR16","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-022-35716-1","volume":"14","author":"J Ast","year":"2023","unstructured":"Ast, J. et al. Revealing the tissue-level complexity of endogenous glucagon-like peptide-1 receptor expression and signaling. Nat. Commun. 14, 301 (2023).","journal-title":"Nat. Commun."},{"key":"1342_CR17","doi-asserted-by":"publisher","first-page":"e164921","DOI":"10.1172\/jci.insight.164921","volume":"8","author":"A Adriaenssens","year":"2023","unstructured":"Adriaenssens, A. et al. Hypothalamic and brainstem glucose-dependent insulinotropic polypeptide receptor neurons employ distinct mechanisms to affect feeding. JCI Insight 8, e164921 (2023).","journal-title":"JCI Insight"},{"key":"1342_CR18","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-020-14309-w","volume":"11","author":"J Ast","year":"2020","unstructured":"Ast, J. et al. Super-resolution microscopy compatible fluorescent probes reveal endogenous glucagon-like peptide-1 receptor distribution and dynamics. Nat. Commun. 11, 467 (2020).","journal-title":"Nat. Commun."},{"key":"1342_CR19","doi-asserted-by":"publisher","first-page":"1007","DOI":"10.1021\/jacsau.2c00130","volume":"2","author":"J Ast","year":"2022","unstructured":"Ast, J. et al. Expanded LUXendin color palette for GLP1R detection and visualization in vitro and in vivo. JACS Au 2, 1007\u20131017 (2022).","journal-title":"JACS Au"},{"key":"1342_CR20","doi-asserted-by":"publisher","first-page":"11529","DOI":"10.1074\/jbc.RA120.014368","volume":"295","author":"SM Gray","year":"2020","unstructured":"Gray, S. M. et al. Discordance between GLP-1R gene and protein expression in mouse pancreatic islet cells. J. Biol. Chem. 295, 11529\u201311541 (2020).","journal-title":"J. Biol. Chem."},{"key":"1342_CR21","doi-asserted-by":"publisher","first-page":"171179","DOI":"10.1016\/j.peptides.2024.171179","volume":"175","author":"AH Shilleh","year":"2024","unstructured":"Shilleh, A. H., Viloria, K., Broichhagen, J., Campbell, J. E. & Hodson, D. J. GLP1R and GIPR expression and signaling in pancreatic alpha cells, beta cells and delta cells. Peptides 175, 171179 (2024).","journal-title":"Peptides"},{"key":"1342_CR22","doi-asserted-by":"publisher","first-page":"e165763","DOI":"10.1172\/jci.insight.165763","volume":"8","author":"N Roman\u00f2","year":"2023","unstructured":"Roman\u00f2, N. et al. Median eminence blood flow influences food intake by regulating ghrelin access to the metabolic brain. JCI Insight 8, e165763 (2023).","journal-title":"JCI Insight"},{"key":"1342_CR23","doi-asserted-by":"publisher","first-page":"463","DOI":"10.2337\/db15-1168","volume":"65","author":"A Michau","year":"2016","unstructured":"Michau, A. et al. Metabolism regulates exposure of pancreatic islets to circulating molecules in vivo. Diabetes 65, 463\u2013475 (2016).","journal-title":"Diabetes"},{"key":"1342_CR24","doi-asserted-by":"publisher","first-page":"248","DOI":"10.1038\/nature22394","volume":"546","author":"Y Zhang","year":"2017","unstructured":"Zhang, Y. et al. Cryo-EM structure of the activated GLP-1 receptor in complex with a G protein. Nature 546, 248\u2013253 (2017).","journal-title":"Nature"},{"key":"1342_CR25","doi-asserted-by":"publisher","first-page":"121","DOI":"10.1038\/nature25773","volume":"555","author":"Y-L Liang","year":"2018","unstructured":"Liang, Y.-L. et al. Phase-plate cryo-EM structure of a biased agonist-bound human GLP-1 receptor\u2013Gs complex. Nature 555, 121\u2013125 (2018).","journal-title":"Nature"},{"key":"1342_CR26","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-022-28683-0","volume":"13","author":"F Zhao","year":"2022","unstructured":"Zhao, F. et al. Structural insights into multiplexed pharmacological actions of tirzepatide and peptide 20 at the GIP, GLP-1 or glucagon receptors. Nat. Commun. 13, 1057 (2022).","journal-title":"Nat. Commun."},{"key":"1342_CR27","doi-asserted-by":"publisher","first-page":"1678","DOI":"10.2337\/diab.42.11.1678","volume":"42","author":"B Thorens","year":"1993","unstructured":"Thorens, B. et al. Cloning and functional expression of the human islet GLP-1 receptor: demonstration that exendin-4 is an agonist and exendin-(9\u201339) an antagonist of the receptor. Diabetes 42, 1678\u20131682 (1993).","journal-title":"Diabetes"},{"key":"1342_CR28","doi-asserted-by":"publisher","first-page":"51","DOI":"10.1016\/j.molmet.2018.12.001","volume":"20","author":"PA Mroz","year":"2019","unstructured":"Mroz, P. A. et al. Optimized GIP analogs promote body weight lowering in mice through GIPR agonism not antagonism. Mol. Metab. 20, 51\u201362 (2019).","journal-title":"Mol. Metab."},{"key":"1342_CR29","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1016\/j.molmet.2018.09.009","volume":"18","author":"T Coskun","year":"2018","unstructured":"Coskun, T. et al. LY3298176, a novel dual GIP and GLP-1 receptor agonist for the treatment of type 2 diabetes mellitus: from discovery to clinical proof of concept. Mol. Metab. 18, 3\u201314 (2018).","journal-title":"Mol. Metab."},{"key":"1342_CR30","doi-asserted-by":"publisher","first-page":"7871","DOI":"10.1039\/D0SC02794D","volume":"11","author":"P Poc","year":"2020","unstructured":"Poc, P. et al. Interrogating surface versus intracellular transmembrane receptor populations using cell-impermeable SNAP-tag substrates. Chem. Sci. 11, 7871\u20137883 (2020).","journal-title":"Chem. Sci."},{"key":"1342_CR31","doi-asserted-by":"publisher","first-page":"5967","DOI":"10.1039\/D1OB02216D","volume":"20","author":"R Birke","year":"2022","unstructured":"Birke, R. et al. Sulfonated red and far-red rhodamines to visualize SNAP- and Halo-tagged cell surface proteins. Org. Biomol. Chem. 20, 5967\u20135980 (2022).","journal-title":"Org. Biomol. Chem."},{"key":"1342_CR32","doi-asserted-by":"publisher","first-page":"321","DOI":"10.1007\/s00125-009-1562-x","volume":"53","author":"M Cnop","year":"2009","unstructured":"Cnop, M. et al. The long lifespan and low turnover of human islet beta cells estimated by mathematical modelling of lipofuscin accumulation. Diabetologia 53, 321\u2013330 (2009).","journal-title":"Diabetologia"},{"key":"1342_CR33","doi-asserted-by":"publisher","first-page":"100466","DOI":"10.1016\/j.xcrm.2021.100466","volume":"2","author":"AMJ Shapiro","year":"2021","unstructured":"Shapiro, A. M. J. et al. Insulin expression and C-peptide in type 1 diabetes subjects implanted with stem cell-derived pancreatic endoderm cells in an encapsulation device. Cell Rep. Med. 2, 100466 (2021).","journal-title":"Cell Rep. Med."},{"key":"1342_CR34","doi-asserted-by":"publisher","first-page":"2047","DOI":"10.1016\/j.stem.2021.10.003","volume":"28","author":"A Ramzy","year":"2021","unstructured":"Ramzy, A. et al. Implanted pluripotent stem-cell-derived pancreatic endoderm cells secrete glucose-responsive C-peptide in patients with type 1 diabetes. Cell Stem Cell 28, 2047\u20132061.e5 (2021).","journal-title":"Cell Stem Cell"},{"key":"1342_CR35","doi-asserted-by":"publisher","first-page":"1042","DOI":"10.1038\/s41587-022-01219-z","volume":"40","author":"D Balboa","year":"2022","unstructured":"Balboa, D. et al. Functional, metabolic and transcriptional maturation of human pancreatic islets derived from stem cells. Nat. Biotechnol. 40, 1042\u20131055 (2022).","journal-title":"Nat. Biotechnol."},{"key":"1342_CR36","doi-asserted-by":"publisher","first-page":"1512","DOI":"10.1073\/pnas.1212137110","volume":"110","author":"M Schaeffer","year":"2013","unstructured":"Schaeffer, M. et al. Rapid sensing of circulating ghrelin by hypothalamic appetite-modifying neurons. Proc. Natl Acad. Sci. USA 110, 1512\u20131517 (2013).","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"1342_CR37","doi-asserted-by":"publisher","first-page":"e3000097","DOI":"10.1371\/journal.pbio.3000097","volume":"17","author":"T Buenaventura","year":"2019","unstructured":"Buenaventura, T. et al. Agonist-induced membrane nanodomain clustering drives GLP-1 receptor responses in pancreatic beta cells. PLoS Biol. 17, e3000097 (2019).","journal-title":"PLoS Biol."},{"key":"1342_CR38","doi-asserted-by":"publisher","first-page":"543","DOI":"10.1038\/nature24264","volume":"550","author":"T Sungkaworn","year":"2017","unstructured":"Sungkaworn, T. et al. Single-molecule imaging reveals receptor\u2013G protein interactions at cell surface hot spots. Nature 550, 543\u2013547 (2017).","journal-title":"Nature"},{"key":"1342_CR39","doi-asserted-by":"publisher","first-page":"8605","DOI":"10.1039\/D1SC06466E","volume":"13","author":"K Ro\u00dfmann","year":"2022","unstructured":"Ro\u00dfmann, K. et al. N-Methyl deuterated rhodamines for protein labelling in sensitive fluorescence microscopy. Chem. Sci. 13, 8605\u20138617 (2022).","journal-title":"Chem. Sci."},{"key":"1342_CR40","doi-asserted-by":"publisher","first-page":"eabf1948","DOI":"10.1126\/sciadv.abf1948","volume":"7","author":"K El","year":"2021","unstructured":"El, K. et al. GIP mediates the incretin effect and glucose tolerance by dual actions on \u03b1\u2009cells and \u03b2\u2009cells. Sci. Adv. 7, eabf1948 (2021).","journal-title":"Sci. Adv."},{"key":"1342_CR41","doi-asserted-by":"publisher","first-page":"257","DOI":"10.2337\/diab.45.2.257","volume":"45","author":"K Moens","year":"1996","unstructured":"Moens, K. et al. Expression and functional activity of glucagon, glucagon-like peptide I, and glucose-dependent insulinotropic peptide receptors in rat pancreatic islet cells. Diabetes 45, 257\u2013261 (1996).","journal-title":"Diabetes"},{"key":"1342_CR42","doi-asserted-by":"publisher","first-page":"170213","DOI":"10.1016\/j.peptides.2019.170213","volume":"125","author":"K El","year":"2020","unstructured":"El, K. & Campbell, J. E. The role of GIP in alpha-cells and glucagon secretion. Peptides 125, 170213 (2020).","journal-title":"Peptides"},{"key":"1342_CR43","doi-asserted-by":"publisher","first-page":"1054","DOI":"10.1016\/j.cmet.2022.06.002","volume":"34","author":"M Imbernon","year":"2022","unstructured":"Imbernon, M. et al. Tanycytes control hypothalamic liraglutide uptake and its anti-obesity actions. Cell Metab. 34, 1054\u20131063.e7 (2022).","journal-title":"Cell Metab."},{"key":"1342_CR44","doi-asserted-by":"publisher","first-page":"1130","DOI":"10.1016\/j.cell.2022.02.011","volume":"185","author":"SE Anton","year":"2022","unstructured":"Anton, S. E. et al. Receptor-associated independent cAMP nanodomains mediate spatiotemporal specificity of GPCR signaling. Cell 185, 1130\u20131142.e11 (2022).","journal-title":"Cell"},{"key":"1342_CR45","doi-asserted-by":"publisher","first-page":"101","DOI":"10.1210\/endrev\/bnaa032","volume":"42","author":"BA McLean","year":"2021","unstructured":"McLean, B. A. et al. Revisiting the complexity of GLP-1 action from sites of synthesis to receptor activation. Endocr. Rev. 42, 101\u2013132 (2021).","journal-title":"Endocr. Rev."},{"key":"1342_CR46","doi-asserted-by":"publisher","first-page":"1050","DOI":"10.1016\/j.cmet.2014.04.005","volume":"19","author":"EricP Smith","year":"2014","unstructured":"Smith, Eric P. et al. The role of \u03b2\u2009cell glucagon-like peptide-1 signaling in glucose regulation and response to diabetes drugs. Cell Metab. 19, 1050\u20131057 (2014).","journal-title":"Cell Metab."},{"key":"1342_CR47","doi-asserted-by":"publisher","first-page":"108","DOI":"10.1016\/j.jneumeth.2016.04.003","volume":"267","author":"KP Nguyen","year":"2016","unstructured":"Nguyen, K. P., O\u2019Neal, T. J., Bolonduro, O. A., White, E. & Kravitz, A. V. Feeding experimentation device (FED): a flexible open-source device for measuring feeding behavior. J. Neurosci. Methods 267, 108\u2013114 (2016).","journal-title":"J. Neurosci. Methods"},{"key":"1342_CR48","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-020-79992-7","volume":"11","author":"S Miyazaki","year":"2021","unstructured":"Miyazaki, S., Tashiro, F., Tsuchiya, T., Sasaki, K. & Miyazaki, J.-I. Establishment of a long-term stable \u03b2-cell line and its application to analyze the effect of Gcg expression on insulin secretion. Sci. Rep. 11, 477 (2021).","journal-title":"Sci. Rep."},{"key":"1342_CR49","doi-asserted-by":"publisher","first-page":"1121","DOI":"10.1038\/nbt.3033","volume":"32","author":"A Rezania","year":"2014","unstructured":"Rezania, A. et al. Reversal of diabetes with insulin-producing cells derived in vitro from human pluripotent stem cells. Nat. Biotechnol. 32, 1121\u20131133 (2014).","journal-title":"Nat. Biotechnol."},{"key":"1342_CR50","unstructured":"Ester, M., Kriegel, H.-P., Sander, J. & Xu, X. A density-based algorithm for discovering clusters in large spatial databases with noise. In KDD\u201996: Proc. 2nd Int. Conf. Knowledge Discovery and Data Mining (eds Simoudis, E. et al.) 226\u2013231 (AAAI Press, 1996)."},{"key":"1342_CR51","doi-asserted-by":"publisher","first-page":"829","DOI":"10.1038\/s41592-022-01507-1","volume":"19","author":"D Ershov","year":"2022","unstructured":"Ershov, D. et al. TrackMate 7: integrating state-of-the-art segmentation algorithms into tracking pipelines. Nat. Methods 19, 829\u2013832 (2022).","journal-title":"Nat. Methods"},{"key":"1342_CR52","doi-asserted-by":"publisher","first-page":"533","DOI":"10.1016\/j.devcel.2010.02.013","volume":"18","author":"O Gavet","year":"2010","unstructured":"Gavet, O. & Pines, J. Progressive activation of CyclinB1-Cdk1 coordinates entry to mitosis. Dev. Cell 18, 533\u2013543 (2010).","journal-title":"Dev. Cell"},{"key":"1342_CR53","doi-asserted-by":"publisher","first-page":"107761","DOI":"10.1016\/j.celrep.2020.107761","volume":"31","author":"K Viloria","year":"2020","unstructured":"Viloria, K. et al. Vitamin-D-binding protein contributes to the maintenance of \u03b1\u2009cell function and glucagon secretion. Cell Rep. 31, 107761 (2020).","journal-title":"Cell Rep."},{"key":"1342_CR54","doi-asserted-by":"publisher","unstructured":"Tarhan, L. et al. Single cell portal: an interactive home for single-cell genomics data. Preprint at https:\/\/doi.org\/10.1101\/2023.07.13.548886 (2023).","DOI":"10.1101\/2023.07.13.548886"}],"container-title":["Nature Metabolism"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s42255-025-01342-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s42255-025-01342-6","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s42255-025-01342-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,9,9]],"date-time":"2025-09-09T02:51:54Z","timestamp":1757386314000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s42255-025-01342-6"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,8,19]]},"references-count":54,"journal-issue":{"issue":"8","published-online":{"date-parts":[[2025,8]]}},"alternative-id":["1342"],"URL":"https:\/\/doi.org\/10.1038\/s42255-025-01342-6","relation":{"has-preprint":[{"id-type":"doi","id":"10.21203\/rs.3.rs-4835197\/v1","asserted-by":"object"}]},"ISSN":["2522-5812"],"issn-type":[{"value":"2522-5812","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,8,19]]},"assertion":[{"value":"31 July 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"24 June 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"19 August 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"J.A., M.C., A.E. and C.A. are employees of Novo Nordisk A\/S. A.E.A. is an employee of AstraZeneca plc. University of Birmingham and Leibniz-Forschungsinstitut f\u00fcr Molekulare Pharmakologie have filed a patent (WO2024133236, \u2018Peptide conjugates for labelling endogenous GIPR and GLP1R\u2019, inventors David J. Hodson and Johannes Broichhagen), which covers daLUXendins described in the present study. Oxford University Innovation filed a PCT patent application on 14 March 2025 (PCT\/GB2025\/050523, entitled \u2018Combination therapy\u2019 and with the inventors being David J. Hodson, Katrina Viloria, Ali Shilleh and Martin Hewison) that encompasses elements of the work described in the present study. This PCT patent application is due to be published on 14 September 2025. D.J.H. and J.B. receive licensing revenue from Celtarys Research for the provision of GLP1R\/GIPR chemical probes used in the present study, including LUXendins, sGIPs and daLUXendins. The remaining authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}]}}